Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Huayu Combined With Entecavir in HBV Liver Cirrhosis
NCT02241590Phase 4Unknown
- Sponsor
- Shuguang Hospital
- Start
- Sep 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fuzheng huayu in Liver cirrhosis (LC), hepatitis B (HBV), sponsored by Shuguang Hospital. Status: unknown.
02
Drugs
fuzheng huayu
03
Conditions
Liver cirrhosis (LC)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02241590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241590.